Charles River Laboratories International, Inc. (CRL)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 192.97 |
| Open | 192.49 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 900 |
| Day's range | 190.32 - 194.14 |
| 52-week range | 161.65 - 275.00 |
| Volume | |
| Avg. volume | 723,893 |
| Market cap | 9.972B |
| Beta (5Y monthly) | 1.36 |
| PE ratio (TTM) | 23.10 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
CRL to Aid Lundbeck's Neurological Drug Research With AI-Backed Logica
Charles River and Lundbeck sign an agreement to use Logica to advance the discovery of novel neurological drugs.
- Simply Wall St.
Charles River Laboratories International, Inc.'s (NYSE:CRL) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
Charles River Laboratories International's (NYSE:CRL) stock is up by 1.0% over the past week. Given that the market...
- Zacks
CRL Stock to Gain From Strategic Neuroscience Partnership With CEBINA
Charles River collaborates with CEBINA as part of the DanubeNeuro program to advance innovation in neurodegeneration.
© 2024 Yahoo. All rights reserved.